You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-MUC1 antibody [M2C5] (HRP) (ab24471)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-MUC1 antibody [M2C5] (HRP)
See all MUC1 products (45) ...

Description

Mouse monoclonal [M2C5] to MUC1 (HRP)

Conjugation

HRP

Specificity

Affinity = > 1.0 x108 Recognizes underglycosylated and natural MUC1 protein. Not cross reactive with normal serum proteins and human tissues of nonepithelial origin.

Tested applications

IHC-Fr, IHC-P, Sandwich ELISA, ELISAmore details

Cross reactivity

Reacts with

Human

Immunogen

High molecular weight (more than 300 kDa) glycoprotein from human milk-fat globule molecule

Epitope

Binds with high efficiency to epitope within the VNTR tandem repeat peptide region of MUC1 molecule.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.1% Sodium Azide
Constituents: 50% Glycerol, PBS, 10mg/ml BSA, pH 7.4

Concentration

Concentration information loading...

Purity

Protein A purified

Primary antibody notes

Detects underglycosylated and natural MUC1 protein

Clonality

Monoclonal

Clone number

M2C5

Myeloma

x63-Ag8.653

Applications

Show applications key

Our Abpromise guarantee covers the use of ab24471 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack.
The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Regulates TP53-mediated transcription and determines cell fate in the genotoxic stress response. Binds, together with KLF4, the PE21 promoter element of TP53 and represses TP53 activity.

Tissue specificity

Expressed on the apical surface of epithelial cells, especially of airway passages, breast and uterus. Also expressed in activated and unactivated T-cells. Overexpressed in epithelial tumors, such as breast or ovarian cancer and also in non-epithelial tumor cells. Isoform 7 is expressed in tumor cells only.

Sequence similarities

Contains 1 SEA domain.

Developmental stage

During fetal development, expressed at low levels in the colonic epithelium from 13 weeks of gestation.

Post-translational
modifications

Highly glycosylated (N- and O-linked carbohydrates and sialic acid). O-glycosylated to a varying degree on serine and threonine residues within each tandem repeat, ranging from mono- to penta-glycosylation. The average density ranges from about 50% in human milk to over 90% in T47D breast cancer cells. Further sialylation occurs during recycling. Membrane-shed glycoproteins from kidney and breast cancer cells have preferentially sialyated core 1 structures, while secreted forms from the same tissues display mainly core 2 structures. The O-glycosylated content is overlapping in both these tissues with terminal fucose and galactose, 2- and 3-linked galactose, 3- and 3,6-linked GalNAc-ol and 4-linked GlcNAc predominating. Differentially O-glycosylated in breast carcinomas with 3,4-linked GlcNAc. N-glycosylation consists of high-mannose, acidic complex-type and hybrid glycans in the secreted form MUC1/SEC, and neutral complex-type in the transmembrane form, MUC1/TM.
Proteolytic cleavage in the SEA domain occurs in the endoplasmic reticulum by an autoproteolytic mechanism and requires the full-length SEA domain as well as requiring a Ser, Thr or Cys residue at the P + 1 site. Cleavage at this site also occurs on isoform MUC1/X but not on isoform MUC1/Y. Ectodomain shedding is mediated by ADAM17.
Dual palmitoylation on cysteine residues in the CQC motif is required for recycling from endosomes back to the plasma membrane.
Phosphorylated on tyrosines and serine residues in the C-terminal. Phosphorylation on tyrosines in the C-terminal increases the nuclear location of MUC1 and beta-catenin. Phosphorylation by PKC delta induces binding of MUC1 to beta-catenin/CTNNB1 and thus decreases the formation of the beta-catenin/E-cadherin complex. Src-mediated phosphorylation inhibits interaction with GSK3B. Src-and EGFR-mediated phosphorylation on Tyr-1229 increases binding to beta-catenin/CTNNB1. GSK3beta-mediated phosphorylation on Ser-1227 decreases this interaction but restores the formation of the beta-cadherin/E-cadherin complex. On T-cell receptor activation, phosphorylated by LCK. PDGFR-mediated phosphorylation increases nuclear colocalization of MUC1CT and CTNNB1.
The N-terminal sequence has been shown to begin at position 24 or 28 (PubMed:11341784).

Cellular localization

Secreted; Cell membrane. Cytoplasm. Nucleus. On EGF and PDGFRB stimulation, transported to the nucleus through interaction with CTNNB1, a process which is stimulated by phosphorylation. On HRG stimulation, colocalizes with JUP/gamma-catenin at the nucleus and Apical cell membrane. Exclusively located in the apical domain of the plasma membrane of highly polarized epithelial cells. After endocytosis, internalized and recycled to the cell membrane. Located to microvilli and to the tips of long filopodial protusions.

Target information above from: UniProt accessionP15941 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Breast carcinoma associated antigen DF3 antibody
  • Breast carcinoma-associated antigen DF3 antibody
  • CA 15 3 antibody
  • CA15 3 antibody
  • CA15 3 antigen antibody
  • CA15.3 antibody
  • Carcinoma associated mucin antibody
  • Carcinoma-associated mucin antibody
  • CD 227 antibody
  • CD227 antibody
  • CD227 antigen antibody
  • DF3 antigen antibody
  • EMA antibody
  • Episialin antibody
  • Epithelial membrane antigen antibody
  • Epithelial mucin tandem repeat sequence antibody
  • H23 antigen antibody
  • H23AG antibody
  • HGNC:7508 antibody
  • KL 6 antibody
  • KL6 antibody
  • MAM 6 antibody
  • MAM6 antibody
  • MUC 1 antibody
  • MUC 1 antibody
  • MUC-1 antibody
  • MUC-1/SEC antibody
  • MUC-1/X antibody
  • MUC1 antibody
  • MUC1-alpha antibody
  • MUC1-beta antibody
  • MUC1-CT antibody
  • MUC1-NT antibody
  • MUC1/ZD antibody
  • MUC1_HUMAN antibody
  • Mucin 1 antibody
  • Mucin 1 precursor antibody
  • Mucin 1 transmembrane antibody
  • Mucin-1 subunit beta antibody
  • Mucin1 antibody
  • Peanut reactive urinary mucin antibody
  • Peanut-reactive urinary mucin antibody
  • PEM antibody
  • PEMT antibody
  • Polymorphic epithelial mucin antibody
  • PUM antibody
  • Tumor associated epithelial membrane antigen antibody
  • Tumor associated epithelial mucin antibody
  • Tumor associated mucin antibody
  • Tumor-associated epithelial membrane antigen antibody
  • Tumor-associated mucin antibody
see all

References for Anti-MUC1 antibody [M2C5] (HRP) (ab24471)

This product has been referenced in:

  • Heinzelmann-Schwarz VAet al. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10:4427-36 (2004).Read more (PubMed: 15240533) »

See 1 publication for this product

Publishing research using ab24471? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"